Article

Tracking Glioma Evolution in human brain for precision medicine by integrating real-time in vivo tumour genomes

2022-04-18

Abstract excerpt

<h4>Background: </h4> Targeted therapy of glioma is unsatisfactory due to the variable heterogeneity of tumors. We tracked glioma genomic alterations in vivo to provide a boost to precision medicine. <h4>Methods: </h4>: We collected tumor tissue samples from glioma patients (including recurrent tumors) and serially collected Tumor in situ fluid (TISF) after surgery. Glioma-derived DNA from these samples was sequen...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 67aa34bb-fe56-5193-8f79-fe0e59838897
DOI: 10.21203/rs.3.rs-1550999/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Tracking Glioma Evolution in human brain for precision medicine by integrating real-time in vivo tumour genomesDOI 10.21203/rs.3.rs-1550999/v1Read

Tumor DNA from tumor in situ fluid was used to track genomic status and evolutionary models of gliomas under first-line treatmentSemantic proximity Read

Real‐time longitudinal analysis of human gliomas reveals in vivo genome evolution and therapeutic impact under standardized treatmentSemantic proximity Read

Characterizing the Genomic Landscape of Brain Glioma With Circulating Tumor DNA From Tumor In Situ FluidSemantic proximity Read

Tumor DNA From Tumor In Situ Fluid Reveals Mutation Landscape of Minimal Residual Disease After Glioma Surgery and Risk of Early RecurrenceSemantic proximity Read

Cerebrospinal fluid-derived genomic alterations tracking gliomaSemantic proximity Read

Plasma ctDNA enables early detection of temozolomide resistance mutations in gliomaSemantic proximity Read

Reveal Postoperative Brain Glioma True Behavior by Real-time Tracking of tumor gene evolution informationSemantic proximity Read

Integrated clonal analysis reveals circulating tumor DNA in urine and plasma of glioma patientsSemantic proximity Read

Cerebrospinal Fluid ctDNA-Based Molecular Assessment of Resection Extent and Prognosis in GliomaSemantic proximity Read

Tumor-initiating genetics and therapy drive divergent molecular evolution in IDH-mutant gliomasSemantic proximity Read

Dynamic Monitoring of Circulating Tumor DNA to Predict the Risk of Non In Situ Recurrence of Postoperative Glioma: A Prospective Cohort StudySemantic proximity Read

The Glioma-IRE project - Molecular profiling in patients with glioma: steps toward an individualized diagnostic and therapeutic approach.Semantic proximity Read